Tanya Simuni, MD

Northwestern Medical Group
  • Clinical Neurophysiology
  • Neurology


Dr. Simuni is the Arthur C. Nielsen Jr. Research Professor and Director of the Parkinson’s Disease and Movement Disorders Center and Associate Professor of Neurology at Northwestern University Feinberg School of Medicine

Dr. Simuni earned her bachelor's of science and medical degrees from Leningrad Medical School, Russia. She served an internship in medicine in Leningrad followed by internship in internal medicine at Albert Einstein Medical Center, Philadelphia, Pennsylvania, and a neurology residency and clinical neurophysiology fellowship at Temple University, Philadelphia. Dr. Simuni completed a fellowship in movement disorders at the University of Pennsylvania Parkinson's Disease and Movement Disorders Center, Philadelphia. Before arriving at Northwestern, she was on faculty at the University of Pennsylvania for three years and served as the medical co-director of the movement disorders surgical program there. She joined the neurology faculty at Northwestern University in 2000 as the Director of the Parkinson's disease and movement disorders program.

Dr. Simuni is an advocate of the multidisciplinary care model for management of all chronic neurological conditions, and has built a multidisciplinary Parkinson's disease center that was awarded the designation of Center of Excellence by the National Parkinson's Foundation and serves as the regional training model. Her research interests include experimental pharmacology, non-motor manifestations of Parkinson's disease and surgical management of Parkinson's disease. As principal or co-investigator of numerous clinical trials, Dr. Simuni has done extensive research on the treatment of Parkinson's disease. She is interested in studying potential disease modifying strategies in Parkinson's disease. Recent projects include a pilot study of tolerability of a putative neuroprotective agent for Parkinson's, impact of surgical treatment of Parkinson's disease (STN DBS) on speech, swallowing, and cognition; efficacy of ramelteon for treatment of REM behavior disorder in Parkinson's disease, incidence and risk factors for impulse control disorders in Parkinson's.

Dr. Simuni has received several prestigious awards including the Dixon Foundation Innovation award, National Parkinson's Foundation research award. She is the Institutional Principal investigator for the National Institutes of Health Exploratory Trials in Parkinson's Disease.


  • Medical Education
    Leningrad University (Ussr) - 1985
  • Residency
    Temple University Hospital - 1994
  • Fellowship
    Temple University Hospital - 1995


  • Neurology


Northwestern Medical Group

675 N. St. Clair

Galter 20-100

Chicago, IL 60611

8:00 a.m. - 5:00 p.m.
8:00 a.m. - 12:00 p.m.
1:00 p.m. - 5:00 p.m.
8:00 a.m. - 5:00 p.m.


  • Atypical Parkinsonian Syndromes
  • Balance Disorders
  • Blepharospasm
  • Botox Injections
  • Dystonia
  • Essential Tremor
  • Gait Disorders
  • Lewy Body Dementia
  • Movement Disorders
  • Parkinson's Disease
  • Progressive Supranuclear Palsy (PSP)
  • Torticollis
  • Tourette Syndrome
  • Tremors
  • Wilson' Disease


  • Russian


  • Aetna EPO
  • Aetna HMO
  • Aetna POS
  • Aetna PPO
  • Aetna US Healthcare HMO
  • BCBS Blue Advantage PPO
  • BCBS Classic Blue
  • Beech Street
  • Blue Choice Supervalu PPO
  • Cigna EPO
  • Cigna HMO
  • Cigna POS
  • Cigna PPO
  • Coventry Health Plan PPO
  • HFN-Healthcares Finest Network
  • HealthLink
  • Humana ChoiceCare POS
  • Humana ChoiceCare PPO
  • Humana HMO
  • Medicaid
  • Medicare
  • Multiplan PPO
  • PNA (Preferred Network Access)
  • PPO Next
  • Preferred Plan PPO
  • TriCare(US Military Insurance)
  • Unicare PPO
  • Unicare PPO(Wellpoint Network)
  • UnitedHealthcare Choice
  • UnitedHealthcare Choice Plus
  • UnitedHealthcare Options PPO
  • UnitedHealthcare Select
  • UnitedHealthcare Select HMO
  • UnitedHealthcare Select Plus